(Q37700755)

22 August 2017

title

Non-erythropoietic tissue-protective peptides derived from erythropoietin: WO2009094172. (English)

1 reference

22 August 2017

1 reference

Francis Dumont

1

1 reference

22 August 2017

Pierre Bischoff

series ordinal

2

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

Expert Opinion on Therapeutic Patents

22 August 2017

published in

1 reference

22 August 2017

volume

20

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

715-723

1 reference

The molecular mechanism of erythropoietin action

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

The non-haematopoietic biological effects of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Raves and risks for erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Antioxidative effects of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Recombinant human erythropoietin in the treatment of acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Erythropoietin biology in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Epoetin-associated pure red cell aplasia: past, present, and future considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

'O', erythropoietin carbamoylation versus carbamylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Derivatives of erythropoietin that are tissue protective but not erythropoietic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

IL-3, IL-5, and GM-CSF signaling: crystal structure of the human beta-common receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Nonerythropoietic tissue protective compounds are highly effective facilitators of wound healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Radiation countermeasure agents: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Carbamylated erythropoietin reduces radiosurgically-induced brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Chronic pharmacological and safety evaluation of Hematide, a PEGylated peptidic erythropoiesis-stimulating agent, in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Erythropoiesis-stimulating agent use in cancer: preclinical and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Eph/ephrin signaling: networks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

A cytokine-cytokine interaction in the assembly of higher-order structure and activation of the interleukine-3:receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Treatment of traumatic brain injury in rats with erythropoietin and carbamylated erythropoietin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Therapeutic window for nonerythropoietic carbamylated-erythropoietin to improve motor function following multiple infarct ischemic strokes in New Zealand white rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Nonerythropoietic derivative of erythropoietin protects against tubulointerstitial injury in a unilateral ureteral obstruction model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Erythropoietin in spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Diabetic neuropathy: therapies on the horizon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Neuroprotective role of erythropoietin by antiapoptosis in the retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

The potential role of erythropoietin in chronic heart failure: from the correction of anemia to improved perfusion and reduced apoptosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Erythropoietin and renoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

The wound healing process: an overview of the cellular and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Stem cells, multiorgan failure in radiation emergency medical preparedness: a U.S./European Consultation Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Emerging drugs for spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

Protective Effect of Erythropoietin and Its Carbamylated Derivative in Experimental Cisplatin Peripheral Neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543771003627464

10.1517/13543771003627464

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference